New hybrid polar differentiation-inducing agent pyroxamide progresses to clinical trials April 17, 2000
Proteasome inhibitor proven to induce apoptosis and to exert antitumor activity in vivo April 17, 2000
U.S. and Brazilian researchers team up to design new ribonucleotide reductase inhibitors April 17, 2000
Selective COX-2 inhibitor reported at AACR meeting to possess antiangiogenic and antitumor activity April 14, 2000
AACR annual meeting chosen by ProIX as forum for presentation of novel class of redox regulators April 14, 2000